BDXLARGE

Becton, Dickinson and Company

HealthcareMedical - Instruments & Supplies
$153.26
$0.09(+5.87%)
52W$100.31
$205.52
Updated May 7, 12:00 AM
RSI32
RS Rating56/99
Beta0.66
Volatility50%
F-Score7/9
Mkt Cap$55.5B
CONSOLIDATING

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

CONSOLIDATING

Becton, Dickinson and Company is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is moderate (RS Rating: 56), indicating performance broadly in line with the market. Earnings growth of 29% provides fundamental context to the price action. Volume support will be critical for the stock to resolve this consolidation to the upside.

Relative Strength
56
out of 99
Average
Trend Score
2/4
Minervini Criteria
CONSOLIDATING
Risk (Beta)
0.66
vs S&P 500
DEFENSIVE
52W Position
50%
from 52W low
Mid Range
Trend & Momentum Analysis

Trend Template (Minervini)

CONSOLIDATING2/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$157.73
50 SMA > 100 SMA$160.47
100 SMA > 150 SMA$149.96
150 SMA > 200 SMA$141.60

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$152.21+0.69%ABOVE
50 SMA$157.73-2.84%BELOW
100 SMA$160.47-4.49%BELOW
150 SMA$149.96+2.20%ABOVE
200 SMA$141.60+8.24%ABOVE

Price Performance

1D+5.9%
1W+2.8%
1M-1.1%
3M-6.0%
6M+39.4%
YTD+0.0%
1Y+48.4%
3Y-0.5%
52-Week Trading Range50% from low
$153.26
52W Low$100.31
52W High$205.52

Technical Indicators

RSI (14)BEARISH
32.2
305070
VCP ScoreCOOL
2/10
Base depth: 28.9%

Risk Profile

Beta
0.66
52W Vol
50%
ATR
$3.31
Max DD (1Y)
-28%

Volume Analysis

Today
5.13M
50D Avg
2.51M
Vol Ratio
2.04x
Liquidity
LIQUID

Earnings Momentum

Q2'25-42%
$1.07
Q3'25+19%
$2.00
Q4'25+19%
$1.72
Q1'26+29%
$1.34
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:+7.82%
5 Years:+6.32%
3 Years:+4.99%
TTM:+6.22%

Compounded Profit Growth

10 Years:+5.70%
5 Years:+16.56%
3 Years:-0.28%
TTM:+1.83%

Stock Price CAGR

10 Years:+4.36%
5 Years:+1.22%
3 Years:-0.47%
1 Year:+48.36%

Return on Equity

10Y Avg:7.1%
5Y Avg:7.0%
3Y Avg:6.3%
Last Year:6.9%

Key Metrics

Market Cap$55.5B
Gross Margin45.4%
Net Margin7.7%
Piotroski F-Score7/9

Frequently Asked Questions

Is BDX in an uptrend right now?

BDX has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.

Is BDX overbought or oversold?

BDX's RSI (14) is 32. The stock is in neutral territory, neither overbought nor oversold.

Is BDX outperforming the market?

BDX has a Relative Strength (RS) Rating of 56 out of 99. BDX is performing about average compared to the market.

Where is BDX in its 52-week range?

BDX is trading at $153.26, which is 75% of its 52-week high ($205.52) and 50% above its 52-week low ($100.31).

How volatile is BDX?

BDX has a Beta of 0.66 and 52-week volatility of 50%. It's less volatile than the S&P 500 - generally more stable.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.